BioPharma Dive 15. Dez. 2025 Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease
BioPharma Dive 15. Dez. 2025 How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress
BioPharma Dive 11. Dez. 2025 Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer
BioPharma Dive 10. Dez. 2025 A former Roivant spinout bets on AI-designed drugs for immune conditions